About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Seattle | 545 Studies

Clinical Trials Breast CancerSeattle

Breast Cancer Clinical Trials in Seattle

Find 545 clinical trials for breast cancer near Seattle, Washington. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 381-400 of 545 trials

TerminatedStudy Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast CancerThis is a phase 2, open-label, multicenter, 2-arm study of bosutinib administered in combination with exemestane versus exemestane alone.NCT00793546·Lake Worth, Florida and 27 others CompletedPhase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast CancerThe purpose of this study was to determine the effects of the weekly regimen of ixabepilone dosing compared to the once every 3 week dosing regimen in participants with metastatic…NCT00593827·Birmingham, Alabama and 56 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPost Market Study Using the Xoft Axxent SystemThe purpose of this multi-center clinical study is to compile post market performance and safety data on the Axxent System.NCT01017549·San Mateo, California and 9 others

CompletedIrinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineThe purpose of this phase II, randomized, open-label clinical trial is to study 2 schedules of single-agent Irinotecan in women with metastatic breast cancer who have experienced…NCT00072852·Mobile, Alabama and 65 others

TerminatedClinical Utility of FES F18 PET/CT in Metastatic Breast Cancer PatientsThis is a phase 4, multi-center, open-label, prospective cohort study to evaluate the clinical utility of Fluoroestradiol F18 (Cerianna) PET/CT to guide therapeutic management in…NCT05068726·Flagstaff, Arizona and 23 others

RecruitingEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in…NCT05879926·Birmingham, Alabama and 1275 others

CompletedComprehensive Patient Reported Outcomes (PRO) Management for Oncology PracticeCancer symptoms due to disease progression or side effects caused by cancer treatment are prevalent. Most cancer patients are treated in outpatient settings.NCT01108315·Tucson, Arizona and 1 other

TerminatedA Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsThe purpose of this study is to compare progression-free survival (PFS) in patients with advanced/metastatic breast cancer who have a BRCA mutation when treated with niraparib as…NCT01905592·Tucson, Arizona and 103 others

CompletedA Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerThe main purpose of this study is to learn if adding bevacizumab to standard treatment with chemotherapy (docetaxel, doxorubicin, and cyclophosphamide) for early stage…NCT00887536·Bessemer, Alabama and 532 others

CompletedCorrelation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast CancerRATIONALE: Timing of breast cancer surgery may improve effectiveness of treatment and may help patients live longer.NCT00002762·Mobile, Alabama and 53 others

CompletedHealthy Families to Change Obesity in Public Housing ResidentsThis is a cluster randomized study of an environmental level intervention to improve nutrition and physical activity, among public housing residents.NCT03111680·Seattle, Washington

Active not recruitingTailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the…NCT03513614·Bethesda, Maryland and 63 others

RecruitingA Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerThis study will evaluate the efficacy and safety of the combination of inavolisib plus a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) and letrozole versus placebo plus a…NCT06790693·Goodyear, Arizona and 241 others

RecruitingA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionThe goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), non-small cell lung…NCT06682793·Gilbert, Arizona and 9 others

Active not recruitingVaccine to Prevent Recurrence in Patients With HER-2 Positive Breast CancerThe main purpose of this study is to evaluate the safety of each study vaccine and to evaluate the effect on the time to disease recurrence (assessed by disease free survival).NCT03384914·Tampa, Florida and 6 others

CompletedEnhancing Connections: Helping the Mother With Breast Cancer Support Her ChildThis is a 6-state randomized controlled trial (RCT) that uses a behavioral intervention to enhance parenting skills for school age children when a mother is recently diagnosed…NCT00194571·Seattle, Washington

RecruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialThis ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing.NCT05564377·Birmingham, Alabama and 483 others

RecruitingS1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerThis randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast…NCT03723928·Anchorage, Alaska and 722 others

RecruitingFirst in Human Study of TUB-030 in Patients With Advanced Solid TumorsThe goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030.NCT06657222·New Haven, Connecticut and 19 others

RecruitingEvaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationThe goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for…NCT05696626·Scottsdale, Arizona and 223 others

PreviousPage 20 of 28Next

Other Conditions in Seattle

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma